Bo Hong
No Rating Available
(Learn About Our Rating System)

Bo Hong, MD

Languages spoken: English

Dr. Hong is an associate professor of clinical pathology at the University of Utah School of Medicine and is a medical director in the Cytogenetics and Genomic Microarray section at ARUP Laboratories. She received her MD from Peking University Health Science Center in China and completed a residency in internal medicine and hematology at People’s Hospital, Peking University, and a clinical cytogenetics fellowship at the University of Utah. She is board certified in Clinical Cytogenetics, and Laboratory Genetics and Genomics by the American Board of Medical Genetics and Genomics, and is a fellow of the American College of Medical Genetics and Genomics. Her academic interests include comprehensive cytogenetic and genomic characterization of hematologic malignancies, particularly childhood leukemia.

Specialties

  • Pathology, Clinical

Board Certification

American Board of Medical Genetics and Genomics (Laboratory Genetics and Genomics)
American Board of Medical Genetics (Clinical Cytogenetics)

Dr. Hong is an associate professor of clinical pathology at the University of Utah School of Medicine and is a medical director in the Cytogenetics and Genomic Microarray section at ARUP Laboratories. She received her MD from Peking University Health Science Center in China and completed a residency in internal medicine and hematology at People’s Hospital, Peking University, and a clinical cytogenetics fellowship at the University of Utah. She is board certified in Clinical Cytogenetics, and Laboratory Genetics and Genomics by the American Board of Medical Genetics and Genomics, and is a fellow of the American College of Medical Genetics and Genomics. Her academic interests include comprehensive cytogenetic and genomic characterization of hematologic malignancies, particularly childhood leukemia.

Board Certification and Academic Information

Academic Departments Pathology -Associate Professor (Clinical)
Board Certification
American Board of Medical Genetics and Genomics (Laboratory Genetics and Genomics)
American Board of Medical Genetics (Clinical Cytogenetics)

Selected Publications

Journal Article

  1. Paulraj P, Diamond S, Razzaqi F, Ozeran JD, Longhurst M, Andersen EF, Toydemir RM, Hong B (2019). Pediatric acute myeloid leukemia with t(7;21)(p22;q22). Genes Chromosomes Cancer, 58(8), 551-557.
  2. Ballout RA, Dickerson C, Wick MJ, Al-Sweel N, Openshaw AS, Srivastava S, Swanson LC, Bramswig NC, Kuechler A, Hong B, Fleming LR, Curry K, Robertson SP, Andersen EF, El-Hattab AW. (2020). Int22h1/Int22h2¿mediated Xq28 duplication syndrome: de novo duplications, prenatal diagnoses, and additional phenotypic features. Hum Mutat, 41(7), 1238-1249.
  3. Tong CR, Hong B, Qiu JY, Chen Z, Lu DP (2002). Significance of cytogenetic and fluorescence in situ hybridization analysis in evaluating antichronic myeloid leukemia efficacy of different immune effector cells. Cancer Genet Cytogenet, 134(1), 21-4.
  4. Chen Z, Pasquini M, Hong B, DeHart S, Heikens M, Tsai (2005). The human Penumbra gene is mapped to a region on chromosome 7 frequently deleted in myeloid malignancies. Cancer genetics and cytogenetics, 162(2), 95-98.
  5. Zhou XA, Louissaint, Jr. A, Wenzel A, Yang J, Martinez-Escala ME, Moy AP, Morgan EA, Paxton CN, Hong B, Andersen EF, Guitart J, Behdad A, Cerroni L, Weistock DM, Choi (2018). Genomic analyses identify recurrent alterations in immune evasion genes in diffuse large B cell lymphoma, leg type. The journal of investigative dermatology. Symposium proceedings, 138(11), 2365-2376.
  6. Hong B, Qiu JY, Dang H, Shi Y, He Q, Lu D (1999). Application of Fluorescence in Situ Hybridization in Detecting the Formation of Variant Ph Chromosome. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 31(5), 400-3.
  7. Cheng SQ, Qiu JY, Lu DP, Hong B, Liu H, Dang H, He Q, Shi Y, Wang D (2000). Detection of Minimal Residual Disease in Patients with Acute Promyelocytic Leukemia by Fluorescence in Situ Hybridization Method. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 32(1), 43-6.
  8. Hong B, Qiu JY, Shi HL,He Q, Tan JH, Shi Y, Dang H, Rong YY, Wang DB, Lu D (1998). Chromosome in Situ Suppression (CISS) Hybridization Applied to the Study of Acute Promyelocytic Leukemia. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 30(1), 29-31.
  9. Qiu JY, Chai Y, He Q,Dang H, Shi Y, Hong B, Shan FX, Wu PN, Lu D (1997). The Evalution of Chromosome Aberration on The Patients with Myelodysplastic Syndrome: Revealment of The Pathogeny of MDS. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 29(3), 207-10.
  10. Hong B, Qiu JY, Wang DB, Chen SS, Wu PN, Dang H, Gu JF, Shan FX, Shi H (1995). Analysis of MIC (Morphorgy, Immunology, Cytogenetics) and Clinical Prognosis in Adult Acute Lymphoblastic Leukemia and Hybrid Leukemia. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 27(5), 343-6.
  11. Hong B, Zunich J, Openshaw A, Toydemir (2017). Clinical Features of Trisomy 12 Mosaicism - Report and Review. American journal of medical genetics. Part A, 173(6), 1681-1686.
  12. Liu H, Qiu JY, Lu DP, Hong B, Shi HL, Shi Y, Dang H, He (2003). A serial study of in cytogenetic change and morphology on the tetra-arsenic tetra-sulfide treatment in untreated or recurrent acute promyelocytic leukemia. Chinese journal of cancer, 25(2), 163-167.
  13. Xiaolong Alan Zhou , Jingyi Yang , Kimberly G. Ringbloom , Maria Estela Martinez-Escala , Kristen E. Stevenson , Alexander T. Wenzel , Damiano Fantini , Haley K. Martin , Andrea P. Moy , Elizabeth A. Morgan , Shannon Harkins , Christian N. Paxton , Bo Hong , Erica F. Andersen , Joan Guitart , David M. Weinstock , Lorenzo Cerroni , Jaehyuk Choi , Abner Louissaint, J (2021). Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features. Blood advances, 5(3), 649-661.
  14. Qiu JY, Tan JH, Wang DB, Hong B, He Q, Dang H, Shi Y, Jiang B, Wu PN, Lu DP, Speicher (1996). Detection of Acute Promyelocytic Leukemia by Morphology, Karyotype and Chromosome in Situ Suppression(CISS) Hybridizaton. 9(4), 146-9.
  15. Qiu JY, Hong B, Wu PN, Dang H, Shan FX, Wang D (1995). Investigation of the Aberrations of Chromosome 16 Associated with Abnormal Cytomorphology in Acute Nonlymphocytic Leukemia. 8(1), 4-7.
  16. Qiu JY, Hong B, Xue ZP, He Q, Zhang YQ, Lu D (1995). Karyotype Evolution and the Effect of Graft against Leukemia. 16(2), 52-4.
  17. Maedeh Mohebnasab, Peng Li, Bo Hong, Jennifer Dunlap, Elie Traer, Guang Fan, Richard D Press, Stephen R Moore, Wei Xi (2023). Cytogenetically Cryptic Acute Promyelocytic Leukemia: A Diagnostic Challenge. Int J Mol Sci. 2023 Aug 22;24(17):13075. Int J Mol Sci, 24(17), 13075. International journal of molecular sciences, 24(17), 13075.
  18. Ting Wen, Gulsen Akay , Janice Palumbos , Betsy Ostrander , Denise Quigley , Allen Lamb , Erica Andersen , Bo Hong , David Viskochi (2025). Vertical inheritance and unique differential phenotypes of reciprocal recombinant chromosome 18 within a multi-generation family. European journal of human genetics,

Conference Proceedings

  1. Tvrdik T, Schafernak K, Jacobsen J, Toydemir R, Walsh A, Hong (2019). Clinical and Cytogenomic Features of Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21 (iAMP21) in the Context of Constitutional Ring Chromosome 21.

Case Report

  1. Chen Z, Hong B, Drozd-Borysiuk E, Coffin C, Albritton (2004). Molecular cytogenetic characterization of a case of Mullerian adenosarcoma. (PMCID 14734223). Cancer genetics and cytogenetics, 148(2), 129-132.
  2. Hong B, Chen Z, Coffin CM, Lemons R, Issa B, Brothman A, Zhou (2003). Molecular cytogenetic analysis of a pleuropulmonary blastoma (PMCID 12660036). Cancer genetics and cytogenetics, 142(1), 65-69.
  3. Hong B, Aston E, Finlinsoni D, Miller A, Brugger C, Issa B, Brothman A, Chen (2001). Ider (17) in Addition to t(15;17) in A Case of Acute Promyelocytic Leukemia. Journal of the Association of Genetic Technologists, 27(3), 101.
  4. Jedrzkiewicz J, Scaife E, Hong B, South S, Alashari (2015). Congenital peribronchial myofibroblastic tumor: Case report and review of literature. Journal of pediatric surgery case reports, 3(4), 154-157.

Letter

  1. Srinivas K. Tantravahi, Bryan D. Huber, Jennie Vagher, Luke Maese, Anthony D. Pomicter, Najla Al-Sweel, Julie D. Asch, Reha M. Toydemir, Bo Hong, Charles Parke (2022). Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia. PMID: 35876645. British Journal of Haematology, 2022 Sep; 198(6), e78-e81.